These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23370770)

  • 1. Lynch syndrome-associated breast cancers do not overexpress chromosome 11-encoded mucins.
    Walsh MD; Cummings MC; Pearson SA; Clendenning M; Walters RJ; Nagler B; Hopper JL; Jenkins MA; Suthers GK; Goldblatt J; Tucker K; Gattas MR; Arnold JL; Parry S; Macrae FA; McGuckin MA; Young JP; Buchanan DD
    Mod Pathol; 2013 Jul; 26(7):944-54. PubMed ID: 23370770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype.
    Walsh MD; Clendenning M; Williamson E; Pearson SA; Walters RJ; Nagler B; Packenas D; Win AK; Hopper JL; Jenkins MA; Haydon AM; Rosty C; English DR; Giles GG; McGuckin MA; Young JP; Buchanan DD
    Mod Pathol; 2013 Dec; 26(12):1642-56. PubMed ID: 23807779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry.
    Walsh MD; Buchanan DD; Cummings MC; Pearson SA; Arnold ST; Clendenning M; Walters R; McKeone DM; Spurdle AB; Hopper JL; Jenkins MA; Phillips KD; Suthers GK; George J; Goldblatt J; Muir A; Tucker K; Pelzer E; Gattas MR; Woodall S; Parry S; Macrae FA; Haile RW; Baron JA; Potter JD; Le Marchand L; Bapat B; Thibodeau SN; Lindor NM; McGuckin MA; Young JP
    Clin Cancer Res; 2010 Apr; 16(7):2214-24. PubMed ID: 20215533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of the chromosome 11 mucin genes in colorectal cancer.
    Sylvester PA; Myerscough N; Warren BF; Carlstedt I; Corfield AP; Durdey P; Thomas MG
    J Pathol; 2001 Oct; 195(3):327-35. PubMed ID: 11673830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer.
    Rakha EA; Boyce RW; Abd El-Rehim D; Kurien T; Green AR; Paish EC; Robertson JF; Ellis IO
    Mod Pathol; 2005 Oct; 18(10):1295-304. PubMed ID: 15976813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma.
    Matsukita S; Nomoto M; Kitajima S; Tanaka S; Goto M; Irimura T; Kim YS; Sato E; Yonezawa S
    Histopathology; 2003 Jan; 42(1):26-36. PubMed ID: 12493022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological characteristics of patients with upper urinary tract urothelial cancer with loss of immunohistochemical expression of the DNA mismatch repair proteins in universal screening.
    Urakami S; Inoshita N; Oka S; Miyama Y; Nomura S; Arai M; Sakaguchi K; Kurosawa K; Okaneya T
    Int J Urol; 2018 Feb; 25(2):151-156. PubMed ID: 29164703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer spectrum in DNA mismatch repair gene mutation carriers: results from a hospital based Lynch syndrome registry.
    Pande M; Wei C; Chen J; Amos CI; Lynch PM; Lu KH; Lucio LA; Boyd-Rogers SG; Bannon SA; Mork ME; Frazier ML
    Fam Cancer; 2012 Sep; 11(3):441-7. PubMed ID: 22714864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast carcinoma and Lynch syndrome: molecular analysis of tumors arising in mutation carriers, non-carriers, and sporadic cases.
    Lotsari JE; Gylling A; Abdel-Rahman WM; Nieminen TT; Aittomäki K; Friman M; Pitkänen R; Aarnio M; Järvinen HJ; Mecklin JP; Kuopio T; Peltomäki P
    Breast Cancer Res; 2012 Jun; 14(3):R90. PubMed ID: 22691310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of membrane-bound mucins (MUC1 and MUC4) and secreted mucins (MUC2, MUC5AC, MUC5B, MUC6 and MUC7) in mucoepidermoid carcinomas of salivary glands.
    Alos L; Lujan B; Castillo M; Nadal A; Carreras M; Caballero M; de Bolos C; Cardesa A
    Am J Surg Pathol; 2005 Jun; 29(6):806-13. PubMed ID: 15897748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential mucin phenotypes and their significance in a variation of colorectal carcinoma.
    Imai Y; Yamagishi H; Fukuda K; Ono Y; Inoue T; Ueda Y
    World J Gastroenterol; 2013 Jul; 19(25):3957-68. PubMed ID: 23840140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is breast cancer a part of Lynch syndrome?
    Ford JM
    Breast Cancer Res; 2012 Aug; 14(4):110. PubMed ID: 22913763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indoleamine 2,3-dioxygenase in endometrial cancer: a targetable mechanism of immune resistance in mismatch repair-deficient and intact endometrial carcinomas.
    Mills A; Zadeh S; Sloan E; Chinn Z; Modesitt SC; Ring KL
    Mod Pathol; 2018 Aug; 31(8):1282-1290. PubMed ID: 29559741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and molecular characteristics of DNA mismatch repair deficient endometrial cancer in a Japanese hospital-based population.
    Yamamoto A; Yamaguchi T; Suzuki O; Ito T; Chika N; Kamae N; Tamaru JI; Nagai T; Seki H; Arai T; Tachikawa T; Akagi K; Eguchi H; Okazaki Y; Ishida H
    Jpn J Clin Oncol; 2021 Jan; 51(1):60-69. PubMed ID: 32844218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Lynch syndrome adenomas, loss of mismatch repair proteins is related to an enhanced lymphocytic response.
    Meijer TW; Hoogerbrugge N; Nagengast FM; Ligtenberg MJ; van Krieken JH
    Histopathology; 2009 Oct; 55(4):414-22. PubMed ID: 19817892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MUC5B expression in gastric carcinoma: relationship with clinico-pathological parameters and with expression of mucins MUC1, MUC2, MUC5AC and MUC6.
    Pinto-de-Sousa J; Reis CA; David L; Pimenta A; Cardoso-de-Oliveira M
    Virchows Arch; 2004 Mar; 444(3):224-30. PubMed ID: 14758553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inverse effects of mucin on survival of matched hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer patients.
    You JF; Hsieh LL; Changchien CR; Chen JS; Chen JR; Chiang JM; Yeh CY; Hsieh PS; Fan CW; Liu CT; Tang R
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4244-50. PubMed ID: 16857798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent loss of mutation-specific mismatch repair protein expression in nonneoplastic endometrium of Lynch syndrome patients.
    Wong S; Hui P; Buza N
    Mod Pathol; 2020 Jun; 33(6):1172-1181. PubMed ID: 31932681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Mismatch Repair Mutation With Age at Cancer Onset in Lynch Syndrome: Implications for Stratified Surveillance Strategies.
    Ryan NAJ; Morris J; Green K; Lalloo F; Woodward ER; Hill J; Crosbie EJ; Evans DG
    JAMA Oncol; 2017 Dec; 3(12):1702-1706. PubMed ID: 28772289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simplified identification of Lynch syndrome: a prospective, multicenter study.
    Bonnet D; Selves J; Toulas C; Danjoux M; Duffas JP; Portier G; Kirzin S; Ghouti L; Carrère N; Suc B; Alric L; Barange K; Buscail L; Chaubard T; Imani K; Guimbaud R
    Dig Liver Dis; 2012 Jun; 44(6):515-22. PubMed ID: 22480969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.